Literature DB >> 26825035

Atazanavir use and carotid intima media thickness progression in HIV: potential influence of bilirubin.

Dominic Chow1, Lindsay Kohorn, Scott Souza, Lishomwa Ndhlovu, Akika Ando, Kalpana J Kallianpur, Mary Margaret Byron, Yvonne Baumer, Sheila Keating, Cecilia Shikuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26825035      PMCID： PMC4793954          DOI： 10.1097/QAD.0000000000000970

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  9 in total

Review 1.  Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin.

Authors:  Harvey A Schwertner; Libor Vítek
Journal:  Atherosclerosis       Date:  2008-03-17       Impact factor: 5.162

2.  Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.

Authors:  Theodoros Kelesidis; Thuy Tien T Tran; James H Stein; Todd T Brown; Carlee Moser; Heather J Ribaudo; Michael P Dube; Robert Murphy; Otto O Yang; Judith S Currier; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2015-04-22       Impact factor: 9.079

3.  Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men.

Authors:  Sasiwarang Goya Wannamethee; Naveed Sattar; Olia Papcosta; Lucy Lennon; Peter H Whincup
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-21       Impact factor: 8.311

4.  Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels.

Authors:  Libor Vítek; Milan Jirsa; Marie Brodanová; Milan Kalab; Zdenek Marecek; Vilém Danzig; Ladislav Novotný; Petr Kotal
Journal:  Atherosclerosis       Date:  2002-02       Impact factor: 5.162

5.  A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness.

Authors:  James H Stein; Heather J Ribaudo; Howard N Hodis; Todd T Brown; Thuy Tien T Tran; Mingzhu Yan; Elizabeth Lauer Brodell; Theodore Kelesidis; Grace A McComsey; Michael P Dube; Robert L Murphy; Judith S Currier
Journal:  AIDS       Date:  2015-09-10       Impact factor: 4.177

6.  The role of carotid arterial intima-media thickness in predicting clinical coronary events.

Authors:  H N Hodis; W J Mack; L LaBree; R H Selzer; C R Liu; C H Liu; S P Azen
Journal:  Ann Intern Med       Date:  1998-02-15       Impact factor: 25.391

7.  Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.

Authors:  Edmund A Bermudez; Nader Rifai; Julie Buring; JoAnn E Manson; Paul M Ridker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

Review 8.  Association of serum bilirubin concentration with risk of coronary artery disease.

Authors:  M Mayer
Journal:  Clin Chem       Date:  2000-11       Impact factor: 8.327

9.  IL-6 and its receptors in coronary artery disease and acute myocardial infarction.

Authors:  Daniel R Anderson; Joseph T Poterucha; Ted R Mikuls; Michael J Duryee; Robert P Garvin; Lynell W Klassen; Scott W Shurmur; Geoffrey M Thiele
Journal:  Cytokine       Date:  2013-04-10       Impact factor: 3.861
  9 in total
  5 in total

1.  Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States.

Authors:  Heidi M Crane; Robin M Nance; Susan R Heckbert; Corey Ritchings; Lisa Rosenblatt; Matthew Budoff; Brian R Wood; David L Tirschwell; H Nina Kim; William C Mathews; Elvin Geng; Richard D Moore; Peter W Hunt; Joseph J Eron; Greer A Burkholder; Daniel R Drozd; Felicia C Chow; Kyra J Becker; Joseph R Zunt; Emily L Ho; Rizwan Kalani; Andrew Huffer; Bridget M Whitney; Michael S Saag; Mari M Kitahata; Joseph A C Delaney
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-15       Impact factor: 3.731

Review 2.  Epidemiology of ischemic heart disease in HIV.

Authors:  Virginia A Triant; Steven K Grinspoon
Journal:  Curr Opin HIV AIDS       Date:  2017-11       Impact factor: 4.283

3.  Cardiovascular outcomes among HIV-infected veterans receiving atazanavir.

Authors:  Joanne LaFleur; Adam P Bress; Lisa Rosenblatt; Jacob Crook; Paul E Sax; Joel Myers; Corey Ritchings
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

Review 4.  Atazanavir and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Patients: A Systematic Review.

Authors:  Dominic Chow; Cecilia Shikuma; Corey Ritchings; Muxing Guo; Lisa Rosenblatt
Journal:  Infect Dis Ther       Date:  2016-09-27

5.  Conflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir.

Authors:  Joshua A Beckman; Brian R Wood; Kevin L Ard; Christin N Price; Daniel A Solomon; Jonah P Zuflacht; Jessica Milian; Joshua C Prenner; Paul E Sax
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.